Faldet i SeSBT/ SeDBT ved 5 uger var henholdsvis 30, 8/ 24, 0 mmHg og 21, 1/ 19, 3 mmHg for irbesartan/ hydrochlorothiazid og irbesartan (p < 0, 0001).
The types and incidences of adverse events reported for patients treated with the combination were similar to the adverse event profile for patients on monotherapy.